| - GRCh37:
- Chr11:6629982
- GRCh38:
- Chr11:6608752
| ILK, TAF10 | V137A, V3A | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37821613-38458253
| CASC3, GSDMB, WIPF2, PNMT, CDC6, TCAP, PSMD3, THRA, LRRC3C, MSL1, ERBB2, RAPGEFL1, NR1D1, GSDMA, IKZF3, CSF3, ORMDL3, MED24, GRB7, MIEN1, ZPBP2, PGAP3 | | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236849974-236925919
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Oct 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236917227-236920952
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236849974-236850119
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236906176-236925919
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (May 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236902582-236902852
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236889216
- GRCh38:
- Chr1:236725916
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630728
- GRCh38:
- Chr11:6609497
| TAF10, ILK | | Primary familial hypertrophic cardiomyopathy | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236881161
- GRCh38:
- Chr1:236717861
| ACTN2 | F44L | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37821662
- GRCh38:
- Chr17:39665409
| TCAP | R17H | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236925896
- GRCh38:
- Chr1:236762596
| ACTN2 | L680F, L638F, L888F | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236924383
- GRCh38:
- Chr1:236761083
| ACTN2 | Q604H, Q812H, Q562H | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236889288
- GRCh38:
- Chr1:236725988
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37821717
- GRCh38:
- Chr17:39665464
| TCAP | | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236900425
- GRCh38:
- Chr1:236737125
| ACTN2 | E13K, E263K, E55K | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Mar 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37821992
- GRCh38:
- Chr17:39665739
| TCAP | T45I | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630098-6630101
- GRCh38:
- Chr11:6608867-6608870
| ILK, TAF10 | | Primary familial hypertrophic cardiomyopathy | Likely benign (Dec 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236898924-236898925
- GRCh38:
- Chr1:236735624-236735625
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236918380
- GRCh38:
- Chr1:236755080
| ACTN2 | K679R, K471R, K429R | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236907922
- GRCh38:
- Chr1:236744622
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6631712
- GRCh38:
- Chr11:6610481
| ILK, TAF10 | R276Q, R349Q, R410Q | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6631059
- GRCh38:
- Chr11:6609828
| ILK, TAF10 | N260D, N187D, N321D | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Aug 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236923026
- GRCh38:
- Chr1:236759726
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jun 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37821954
- GRCh38:
- Chr17:39665701
| TCAP | | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Likely benign (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236918342
- GRCh38:
- Chr1:236755042
| ACTN2 | Q458H, Q666H, Q416H | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236906176
- GRCh38:
- Chr1:236742876
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236902730
- GRCh38:
- Chr1:236739430
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236918464
- GRCh38:
- Chr1:236755164
| ACTN2 | V499A, V707A, V457A | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236912512
- GRCh38:
- Chr1:236749212
| ACTN2 | A327V, A535V, A285V | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6631070
- GRCh38:
- Chr11:6609839
| ILK, TAF10 | | Primary familial hypertrophic cardiomyopathy | Likely benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630723
- GRCh38:
- Chr11:6609492
| ILK, TAF10 | | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37822036
- GRCh38:
- Chr17:39665783
| TCAP | L60V | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236924339
- GRCh38:
- Chr1:236761039
| ACTN2 | M590V, M798V, M548V | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37822322
- GRCh38:
- Chr17:39666069
| TCAP | S155C | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236902723
- GRCh38:
- Chr1:236739423
| ACTN2 | P83R, P125R, P333R | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Oct 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236883406
- GRCh38:
- Chr1:236720106
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Mar 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236924453
- GRCh38:
- Chr1:236761153
| ACTN2 | R586W, R628W, R836W | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630392
- GRCh38:
- Chr11:6609161
| ILK, TAF10 | | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Jun 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236918432
- GRCh38:
- Chr1:236755132
| ACTN2 | | Primary familial hypertrophic cardiomyopathy, Dilated cardiomyopathy 1AA | Likely benign (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236900506
- GRCh38:
- Chr1:236737206
| ACTN2 | A82T, A290T, A40T | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Jul 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236920802
- GRCh38:
- Chr1:236757502
| ACTN2 | W474*, W516*, W724* | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236914783
- GRCh38:
- Chr1:236751483
| ACTN2 | A557V, A349V, A307V | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Oct 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236920845
- GRCh38:
- Chr1:236757545
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630560
- GRCh38:
- Chr11:6609329
| ILK, TAF10 | I156F, I217F, I83F | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236917393
- GRCh38:
- Chr1:236754093
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37822183
- GRCh38:
- Chr17:39665930
| TCAP | T109A | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37821955
- GRCh38:
- Chr17:39665702
| TCAP | | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Likely benign (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630184
- GRCh38:
- Chr11:6608953
| TAF10, ILK | P141S, T173I, T39I | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236850019
- GRCh38:
- Chr1:236686719
| ACTN2 | E16K | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236918354
- GRCh38:
- Chr1:236755054
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jan 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236918360
- GRCh38:
- Chr1:236755060
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630963
- GRCh38:
- Chr11:6609732
| TAF10, ILK | V289M, V155M, V228M | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236898939
- GRCh38:
- Chr1:236735639
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jul 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236908058
- GRCh38:
- Chr1:236744758
| ACTN2 | A213G, A463G, A255G | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236907968
- GRCh38:
- Chr1:236744668
| ACTN2 | S183W, S225W, S433W | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6629949
- GRCh38:
- Chr11:6608719
| TAF10, ILK | V126A | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630808
- GRCh38:
- Chr11:6609577
| TAF10, ILK | P265L, P131L, P204L | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236889226
- GRCh38:
- Chr1:236725926
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236914924
- GRCh38:
- Chr1:236751624
| ACTN2 | M604T, M354T, M396T | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Dec 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6629926
- GRCh38:
- Chr11:6608696
| ILK, TAF10 | | Primary familial hypertrophic cardiomyopathy | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6629424
- GRCh38:
- Chr11:6608194
| ILK, TAF10 | R80C | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236883386
- GRCh38:
- Chr1:236720086
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37821644-37821645
- GRCh38:
- Chr17:39665391-39665392
| TCAP | | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236920773
- GRCh38:
- Chr1:236757473
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236914882
- GRCh38:
- Chr1:236751582
| ACTN2 | N340S, N590S, N382S | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy, Cardiovascular phenotype
| Conflicting interpretations of pathogenicity (Dec 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:236882180
- GRCh38:
- Chr1:236718880
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236894518
- GRCh38:
- Chr1:236731218
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236898922
- GRCh38:
- Chr1:236735622
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (May 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37822306
- GRCh38:
- Chr17:39666053
| TCAP | G150R | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Uncertain significance (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236906197
- GRCh38:
- Chr1:236742897
| ACTN2 | D120V, D162V, D370V | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630350
- GRCh38:
- Chr11:6609119
| ILK, TAF10 | N60T, N194T | Primary familial hypertrophic cardiomyopathy | Uncertain significance (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236920809
- GRCh38:
- Chr1:236757509
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (May 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236850038
- GRCh38:
- Chr1:236686738
| ACTN2 | Q22R | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236920843
- GRCh38:
- Chr1:236757543
| ACTN2 | V530M, V488M, V738M | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236890988
- GRCh38:
- Chr1:236727688
| ACTN2 | G183C | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236850040
- GRCh38:
- Chr1:236686740
| ACTN2 | E23Q | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630611
- GRCh38:
- Chr11:6609380
| ILK, TAF10 | D100N, D173N, D234N | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630211
- GRCh38:
- Chr11:6608980
| TAF10, ILK | | Primary familial hypertrophic cardiomyopathy | Likely benign (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6631675
- GRCh38:
- Chr11:6610444
| TAF10, ILK | | Primary familial hypertrophic cardiomyopathy | Likely benign (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236925910
- GRCh38:
- Chr1:236762610
| ACTN2 | S892R, S642R, S684R | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236912580
- GRCh38:
- Chr1:236749280
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Apr 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236920791
- GRCh38:
- Chr1:236757491
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Apr 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236889242
- GRCh38:
- Chr1:236725942
| ACTN2 | A153V | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236891058-236891060
- GRCh38:
- Chr1:236727758-236727760
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236908019
- GRCh38:
- Chr1:236744719
| ACTN2 | D242G, D200G, D450G | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Mar 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236917368
- GRCh38:
- Chr1:236754068
| ACTN2 | Q404R, Q446R, Q654R | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236917326
- GRCh38:
- Chr1:236754026
| ACTN2 | R390L, R432L, R640L | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236894536
- GRCh38:
- Chr1:236731236
| ACTN2 | D207Y | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Sep 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236898927
- GRCh38:
- Chr1:236735627
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236883426
- GRCh38:
- Chr1:236720126
| ACTN2 | K128R | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37822286
- GRCh38:
- Chr17:39666033
| TCAP | V143G | Hypertrophic cardiomyopathy 25, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236920778
- GRCh38:
- Chr1:236757478
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236924460
- GRCh38:
- Chr1:236761160
| ACTN2 | L838R, L630R, L588R | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236917330
- GRCh38:
- Chr1:236754030
| ACTN2 | Q433H, Q641H, Q391H | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236914921
- GRCh38:
- Chr1:236751621
| ACTN2 | T353I, T603I, T395I | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:6630530
- GRCh38:
- Chr11:6609299
| ILK, TAF10 | L146V, L207V, L73V | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236912500
- GRCh38:
- Chr1:236749200
| ACTN2 | W281*, W323*, W531* | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Uncertain significance (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236900531
- GRCh38:
- Chr1:236737231
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:236902850
- GRCh38:
- Chr1:236739550
| ACTN2 | | Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy | Likely benign (Feb 22, 2022) | criteria provided, single submitter |